Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;6(1):44-51.
doi: 10.1111/j.1750-2659.2011.00266.x. Epub 2011 Jun 14.

Maternal outcomes among pregnant women receiving live attenuated influenza vaccine

Affiliations

Maternal outcomes among pregnant women receiving live attenuated influenza vaccine

Seth L Toback et al. Influenza Other Respir Viruses. 2012 Jan.

Abstract

Background: Although the live attenuated influenza vaccine (LAIV) prescribing information contains warnings/precautions against use during pregnancy, administration of LAIV to pregnant women does occur. Data regarding maternal outcomes after LAIV administration during pregnancy are limited.

Objectives: Maternal outcomes after LAIV vaccination during pregnancy were examined.

Methods: Data from a health insurance claims database that covers approximately 50 million individuals were analyzed for the six influenza seasons from 2003-2004 through 2008-2009. Emergency department (ED) visits and hospitalizations occurring within 42 days of vaccination were analyzed by primary diagnosis; outcomes were categorized as cardiopulmonary, obstetric, and other. Cohort characteristics were analyzed using descriptive statistics.

Results: Of 834,999 pregnancies identified, 138 (0·017%) were among women who received LAIV vaccinations. Of the 138 pregnant women, 13% were ≤19 years, 67% were 20-34 years, and 20% were ≥35 years of age. Eight events occurred within 42 days of vaccination: one ED visit for bronchitis, two hospitalizations for hyperemesis gravidarum and premature labor, and five ED visits/hospitalizations for common medical conditions. All outcomes identified after LAIV exposure occurred at rates similar to rates in unvaccinated pregnant women reported in the medical literature.

Conclusions: Administration of LAIV to pregnant women is rare; the rate has remained constant since 2004-2005. In this cohort, there was no evidence of significant maternal adverse outcomes after receipt of LAIV. These data may offer some reassurance to providers and pregnant women in the event of inadvertent LAIV administration, but do not support the routine use of LAIV in pregnant women.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trimester of vaccination with LAIV by influenza season (season defined as September–February). LAIV, live attenuated influenza vaccine. *Because the data analyzed included deliveries through September 2009, the 2008–2009 cohort may be missing some first‐trimester vaccinations (see Methods for full description).

References

    1. Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1–62. - PubMed
    1. Lindsay L, Jackson LA, Savitz DA et al. Community influenza activity and risk of acute influenza‐like illness episodes among healthy unvaccinated pregnant and postpartum women. Am J Epidemiol 2006; 163:838–848. - PubMed
    1. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094–1102. - PubMed
    1. American College of Obstetricians and Gynecologists (ACOG) . Immunization updates for pregnant women in influenza season 2010 Available at: http://www.acog.org/acog_sections/dist_notice.cfm?recno=27&bulletin=2592 (Accessed 6 April 2011).
    1. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008; 8:44–52. - PubMed

Publication types